期刊文献+

1-甲基色氨酸联合外周血单个核细胞对人胶质瘤细胞的免疫杀伤作用

Immune killing effects of 1-methyltroptophan combined with peripheral blood mononuclear cells on human glioma cells
原文传递
导出
摘要 目的 观察吲哚胺-2,3-双加氧酶(IDO)抑制剂1-甲基色氨酸(1-MT)联合外周血单个核细胞(PBMC)对人胶质瘤细胞A172的免疫杀伤作用.方法 采用Ficoll密度梯度离心分离健康人外周血制备PBMC,根据是否联合1-MT分组.细胞计数试剂盒(CCK-8)法检测梯度1-MT(0、25、125、250、500 μmol/L;1、2、4、8、10 mmol/L)联合PBMC对A172细胞存活率影响.1-MT(500 μmol/L)联合PBMC与A172细胞共培养,流式双染术检测A172细胞凋亡率,Western blot检测A172细胞IDO蛋白表达,实时定量反转录聚合酶链反应(RT-qPCR)检测PBMC中调节T细胞叉头样螺旋转录因子(Foxp3) mRNA表达.结果 在PBMC数量一定情况下,1-MT呈剂量依赖性抑制A172细胞存活率;1-MT联合PBMC组细胞凋亡比率(45.0%)显著高于PBMC组(20.0%)及1-MT组(33.7%);PBMC组A172细胞IDO蛋白相对表达量(0.313±0.017)明显高于1-MT联合PBMC组(0.182±0.015,P<0.01),1-MT、A172空白组未见明显IDO蛋白表达;PBMC组PBMC中Foxp3mRNA表达(2.764±0.180)明显高于1-MT联合PBMC组(2.189 ±0.179,P<0.05)及PBMC空白组(1.000±0.028,P<0.01),1-MT联合PBMC组明显高于PBMC空白组(P<0.01).结论 1-MT可抑制IDO表达,下调PBMC中Foxp3转录因子表达,降低调节性T细胞增殖分化,可增强PBMC对胶质瘤细胞免疫杀伤作用. Objective To investigate the immune killing effects of 1-methyltroptophan (1-MT)combined with peripheral blood mononuclear cells (PBMC) on human A172 glioma cells and the relative mechanism.Methods PBMC were isolated from healthy donors by Ficoll density-gradient centrifugation.A172 cells were co-cultured with or without PBMC in the presence or absence of 1-MT.Cell counting kit-8 (CCK-8) assay was used to test the inhibitory effect of 1-MT (0,25,125,250,500 μmol/L; 1,2,4,8,10 mmol/L) combined with PBMC on growth of A172 cells.Annexin V/propidium iodide (PI) staining was used to detect the effect of 1-MT (500 μmol/L) combined with PBMC on apoptosis of A172 cells.The expression of indoleamine 2,3-dioxygenase (IDO) protein in A172 cells was detected by Western blotting in different groups.The expression changes of forkhead helix transcription factor p3 (Foxp3) mRNA in PBMC were investigated by real-time quantitative polymerase chain reaction (RT-qPCR).Results 1-MT reduced the growth rate of A172 glioma cells in a dose-dependent manner under the condition of a constant PBMC amount.The apoptosis rate of A172 cells induced by combined 1-MT and PBMC (45.0%) was significantly higher than that induced by either 1-MT (33.7%) or PBMCs (20.0%).Western blotting analysis showed that the expression of IDO was considerably lower in 1-MT + PBMC group (0.182 ±0.015) than in PBMC group (0.313 ±0.017).1-MT group and A172 blank group showed no significant IDO expression.The mRNA level of Foxp3 was significantly higher in PBMC group (2.764 ± 0.180) than in 1-MT + PBMC group (2.189 ±0.179) and PBMC blank group (1.000 ± 0.028) by RT-qPCR.Conclusion 1-MT can significantly increase the immune killing effects of PBMC by inhibiting the expression of IDO and Foxp3 and the differentiation of Treg cells in A172 cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第3期528-530,共3页 Chinese Journal of Experimental Surgery
关键词 吲哚胺-2 3-双加氧酶 胶质瘤细胞 外周血单个核细胞 脱噬作用 Indoleamine 2,3-dioxygenase Glioma cells Peripheral blood mononuclear cells Apoptosis
  • 相关文献

参考文献7

  • 1Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with con- comitant and adjuvant temozolomide versus radiotherapy alone on sur- vival in glioblastoma in a randomised phase HI study: 5-year analysis of the EORTC -NCIC trial [ J ]. Lancet Oncol, 2009,10 ( 5 ) :459 -466.
  • 2Wainwright DA, Dey M, Chang A, et al. Targeting Tregs in malignant brain cancer: overcoming IDO[ J ]. Front Imnmno1,2013,4 : 116.
  • 3Wainwright DA,Balyasnikova IV,Chang AL, et al. IDO expression in brain tumors increases the recruitment of regulatory T cells and nega- tively impacts survival [ J ]. Clin Cancer Res, 2012,18 ( 22 ) : 6110- 6121.
  • 4Mitsuka K, Kawataki T, Satoh E, et al. Expression of indoleamine 2,3- dioxygenase and correlation with pathological malignancy in gliomas [ J ]. Neurosurgery, 2013,72 ( 6 ) : 1031-1038.
  • 5刘宝辉,沈恒,陈谦学,冀保卫,郭振涛,吴立权.树突细胞肿瘤疫苗对U251细胞的作用[J].中华实验外科杂志,2011,28(5):817-818. 被引量:4
  • 6冀保卫,陈谦学,田道锋,刘宝辉,吴立权,郭振涛,纪振刚.胶质瘤干细胞疫苗治疗恶性脑胶质瘤[J].中华实验外科杂志,2011,28(4):638-638. 被引量:2
  • 7李元栋,徐钧,邹浩军,王春友.1-甲基色氨酸对胰腺癌荷瘤鼠中调节性T细胞数量变化的影响[J].中华实验外科杂志,2010,27(1):15-17. 被引量:2

二级参考文献13

  • 1王德俊,袁小芳,孙华文,沈世强.反义IDO-AFP基因融合修饰树突状细胞抗肝癌免疫作用[J].中华实验外科杂志,2006,23(8):948-950. 被引量:3
  • 2Gilboa E.DC-based cancer vaccines.J Clin Inves,2007,117:1195-1204.
  • 3Puccetti P,Grohmann U.IDO and regulatory T cells:a role for revers signalling and non-canonical NF-κB activation.Nat Rev Immunol,2007,7:817-823.
  • 4Ou XL,Cai SH.Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor,1-MT.J Cancer Res Clin Oncol,2008,134:525-533.
  • 5Banchereau J,Schuler-Thumer B,Palucka AK,et al.Dendritic cells as vectors for therapy.Cell,2001,106:271-274.
  • 6Liu G,Khong HT,Wheeler CJ,et al.Molecuhand functional analysis of tyrosictase-related protein (TRP)-2 as a cytotoxic Tlymphocyte target in patients with m alignant glioma.Immunother,2003,26:301-312.
  • 7Koido S, Hara E, Homma S, et al. Cancer vaccine by fusions of dendritic and cancer ceils. Clin Dev Immunol, 2009,2009:657- 369.
  • 8冀保卫 田道锋 陈谦学 等.脑胶质瘤干细胞的培养及鉴定[J].中华实验外科杂志,:190-190.
  • 9李元栋,邹浩军,徐钧,王春友.胰腺癌荷瘤鼠吲哚胺2,3-双加氧酶表达和CD4^+CD25^+Treg细胞数的变化[J].中华实验外科杂志,2009,26(11):1481-1482. 被引量:5
  • 10王军民,沈恒,田道锋,陈谦学,冀保卫,刘宝辉.热诱导人胶质瘤U251细胞凋亡作用[J].中华实验外科杂志,2009,26(11):1489-1490. 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部